- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06517368
Ultrasound Elastography Combined With Conventional Mri in Differentiating Solid Renal Parenchyma Masses
July 18, 2024 updated by: Hager Mohamed Sayed, Assiut University
Ultrasound Elastography Combined With Conventional MRI in Differentiating Solid Renal Parenchyma Masses
Investigate the diagnostic accuracy of Ultrasound Elastography combined with conventional MRI in evaluation of solid renal masses using histopathology as a gold standard.
Study Overview
Detailed Description
Renal masses are increasingly detected incidentally during imaging that plays a key role in the characterization of these masses.
Renal masses are a biologically heterogeneous group of tumors ranging from benign masses to cancers that can be indolent or aggressive.Typical imaging methods available for differentiating benign from malignant renal lesions include ultrasound (US), contrast-enhanced ultrasound (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI).
Renal mass biopsy is considered the gold standard for determining the presurgical histology of renal masses.
US can easily characterize most incidental renal masses , but it cannot always differentiate between benign and malignant solid renal tumors.MR imaging has been gaining popularity in recent years as a problem-solving tool in the evaluation of renal masses.It has several advantages including no exposure to radiation and a superior soft-tissue contrast, and may be a feasible initial imaging option for characterization of renal tumors.Ultrasound elastography (USE) is an imaging technology sensitive to tissue stiffness that was first described in the 1990s.It takes advantage of the changed elasticity of soft tissues resulting from specific pathological or physiological processes.
Ultrasound-based methods include strain elastography, two-dimensional shear wave elastography (2D-SWE), point shear wave elastography (pSWE), and vibration-controlled transient elastography (VCTE).
US elastography is a non-invasive technique that can assess tissue elasticity, has shown promising results in many clinical settings, and could be able to differentiate between benign and malignant renal lesions based on tissue stiffness.
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hager Mohamed Sayed, Master
- Phone Number: 01119330514
- Email: hagermohamed7127@gmail.com
Study Contact Backup
- Name: Ahmed Mostafa Hamed
- Phone Number: 01000024182
- Email: ahmed.hamed2@med.aun.edu.eg
Study Locations
-
-
-
Assiut, Egypt
- Assuit university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The patients will undergo both B-mode and sonoelastographic examinations in the supine and lateral decubitus position and will perform during breath-holding after deep inspiration.
The elastogram was displayed over the B-mode image in a color scale: red (greatest strain, softest tissue component), green (average strain, intermediate tissue component), and blue (no strain, hardest tissue component) Patients will be examined by MRI with diffusion images and ADC values.
Description
Inclusion Criteria:
- patient with solid renal masses.
Exclusion Criteria:
- patient with cystic renal masses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
benign solid renal masses
|
The patients will undergo both B-mode and sonoelastographic examinations in the supine and lateral decubitus position and will perform during breath-holding after deep inspiration.
The elastogram was displayed over the B-mode image in a color scale: red (greatest strain, softest tissue component), green (average strain, intermediate tissue component), and blue (no strain, hardest tissue component) Patients will be examined by MRI with diffusion images and ADC values.
|
|
malignant solid renal masses
|
The patients will undergo both B-mode and sonoelastographic examinations in the supine and lateral decubitus position and will perform during breath-holding after deep inspiration.
The elastogram was displayed over the B-mode image in a color scale: red (greatest strain, softest tissue component), green (average strain, intermediate tissue component), and blue (no strain, hardest tissue component) Patients will be examined by MRI with diffusion images and ADC values.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ultrasound Elastography combined with conventional mri in differentiating solid renal parenchyma masses
Time Frame: Baseline
|
Investigate the diagnostic accuracy of Ultrasound Elastography combined with conventional MRI in evaluation of solid renal masses using histopathology as a gold stsndard.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 10, 2024
Primary Completion (Estimated)
December 30, 2025
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
July 18, 2024
First Submitted That Met QC Criteria
July 18, 2024
First Posted (Actual)
July 24, 2024
Study Record Updates
Last Update Posted (Actual)
July 24, 2024
Last Update Submitted That Met QC Criteria
July 18, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- renal masses
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Masses
-
University Health Network, TorontoWithdrawn
-
St. Joseph's Healthcare HamiltonUnknown
-
St. Joseph's Healthcare HamiltonActive, not recruitingSmall Renal Masses (SRM)Canada
-
Mahidol UniversityRecruiting
-
Peking Union Medical College HospitalCompletedPancreatic Masses
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownMediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver MassesUnited States
-
Brugmann University HospitalCompletedAdnexal MassesBelgium
-
Asan Medical CenterCompletedPancreatic MassesKorea, Republic of
-
Shandong UniversityUnknownSolid Pancreatic MassesChina
-
The Third Xiangya Hospital of Central South UniversityUnknownSolid Pancreatic MassesChina
Clinical Trials on MRI, Ultrasound
-
University of Illinois at ChicagoCompleted
-
Sohag UniversityNot yet recruitingShoulder Impingement SyndromeEgypt
-
Ain Shams UniversityUnknownPlacenta Accreta, Third TrimesterEgypt
-
Institute of Cancer Research, United KingdomCancer Research UKCompleted
-
Assiut UniversityUnknownSalivary Gland Diseases
-
University Hospital MuensterCompleted
-
University of South FloridaCompleted
-
Sohag UniversityNot yet recruitingPatient's With Rheumatoid ArthritisEgypt
-
University of ExeterCompleted